跳至主要内容
临床试验/CTRI/2018/03/012578
CTRI/2018/03/012578尚未招募未知

Demographic profile of hepatocellular carcinoma in three tertiary care referral centres

Tata Memorial Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • All patients with a diagnosis of hepatocellular carcinoma.
  • -HCC will be diagnosed according to Modified European Association for study of Liver (EASL) criteria which includes either biopsy or any two of the following three:
  • a. AFP >300 ng/dl
  • b. Arterial enhancement and venous phase washout on CECT
  • c. Arterial enhancement and venous phase washout on MRI.
  • Staging of HCC will be done according to Barcelona Clinic Liver Cancer (BCLC) classification.

排除标准

  • Other space occupying lesions in liver like metastasis or primary benign tumors will be excluded from the study

研究者

相似试验

Details of patients with Hepatocellular cancer in... | 临床试验